Population Pharmacokinetics and Pharmacodynamics of Propofol in Morbidly Obese Patients

Author： >

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.50, Iss.11, 2011-11, pp. : 739-750

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Software for Population Pharmacokinetics and Pharmacodynamics

By Aarons L.

Clinical Pharmacokinetics, Vol. 36, Iss. 4, 1999-04 ,pp. : 255-264

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics and Pharmacodynamics of Lampalizumab Administered Intravitreally to Patients With Geographic Atrophy

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 10, 2015-10 ,pp. : 595-604

John Wiley & Sons Inc

Access to resources Recommend Favorite

Propofol Pharmacokinetics in Patients with Obstructive Jaundice

Current Drug Delivery, Vol. 6, Iss. 3, 2009-07 ,pp. : 317-320

Bentham Science Publishers

Access to resources Recommend Favorite

Population Pharmacokinetics and Pharmacodynamics of Cinaciguat, a Soluble Guanylate Cyclase Activator, in Patients with Acute Decompensated Heart Failure

By Mueck Wolfgang Frey Reiner

Clinical Pharmacokinetics, Vol. 49, Iss. 2, 2010-02 ,pp. : 119-129

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban - an Oral, Direct Factor Xa Inhibitor - in Patients Undergoing Major Orthopaedic Surgery

By Mueck Wolfgang

Clinical Pharmacokinetics, Vol. 47, Iss. 3, 2008-01 ,pp. : 203-216

Adis International

Access to resources Recommend Favorite